Intra-Cellular Therapies Inc. buy Royal Bank of Canada
Start price
03.11.23
/
50%
€51.40
Target price
03.11.24
€70.83
Performance (%)
40.08%
Price
08:04
€74.00
Summary
This prediction is currently active. With a performance of 40.08% the BUY prediction by Royal_Bank_of_Canada is a big success. This prediction currently runs until 03.11.24. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Intra-Cellular Therapies Inc. | 8.696% | 8.696% |
iShares Core DAX® | 0.039% | 0.567% |
iShares Nasdaq 100 | -4.018% | -5.554% |
iShares Nikkei 225® | -2.389% | -1.434% |
iShares S&P 500 | -2.115% | -2.351% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Intra-Cellular Therapies Inc. diskutieren
Intra-Cellular Therapies, Inc. (NASDAQ: ITCI) had its price target lowered by analysts at Royal Bank of Canada from $77.00 to $76.00. They now have an "outperform" rating on the stock.
Ratings data for ITCI provided by MarketBeat
Stopped prediction by Royal_Bank_of_Canada for Intra-Cellular Therapies Inc.
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€69.00
25.06.24
25.06.24
€96.23
25.06.25
25.06.25
8.70%
08:04
08:04
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€62.50
03.04.24
03.04.24
€79.68
03.04.25
03.04.25
20.00%
08:04
08:04
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€64.80
23.02.24
23.02.24
€79.43
23.02.25
23.02.25
15.74%
08:04
08:04
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€63.60
31.01.24
31.01.24
€79.15
31.01.25
31.01.25
17.92%
08:04
08:04
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€53.50
04.08.23
04.08.23
€71.56
04.08.24
04.08.24
40.19%
08:04
08:04
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€44.00
02.03.23
02.03.23
€67.06
02.03.24
02.03.24
50.68%
03.03.24
03.03.24